Studies on adjuvants for human prophylactics. I. Comparison of efficiencies of different adjuvants at various stages of immunization with tetanus and diphtheria toxoids
- PMID: 732031
- DOI: 10.7883/yoken1952.31.263
Studies on adjuvants for human prophylactics. I. Comparison of efficiencies of different adjuvants at various stages of immunization with tetanus and diphtheria toxoids
Abstract
Kinetic studies on the adjuvanticities of several substances with different modes of action were performed in guinea pigs by using tetanus and diphtheria toxoids as the antigens. When injected subcutaneously into animals, aluminium, endotoxin, pertussis vaccine and water in oil in water (w/o/w) showed very similar adjuvanticities to tetanus toxoid at the beginning stage of immunization, but the activities except that of aluminium became less significant at later stages after the primary stimulus when antitoxin was produced abundantly. Poly L-lysine and to a less extent poly A:U showed potent adjuvanticities next to that of aluminium throughout the whole immunization period. Combination of poly L-lysine with 0.03 mg aluminium showed a similar adjuvanticity to that of 0.9 mg of aluminium alone. In contrast to rather low adjuvanticities to tetanus toxoid, more distinct adjuvanticities were observed to diphtheria toxoid throughout the whole period of immunization with various substances such as aluminium, poly A:U, w/o/w and poly L-lysine but not with endotoxin.
Similar articles
-
Studies on adjuvants for human prophylactics. II. Influence of the route of injection on the activity of adjuvants to tetanus toxoid in guinea pigs.Jpn J Med Sci Biol. 1978 Oct-Dec;31(5-6):393-406. Jpn J Med Sci Biol. 1978. PMID: 156804
-
Adjuvanticity of pGPL-Mc and LRS in the immune responses of monkeys to oral immunization with diphtheria and tetanus toxoids.Comp Immunol Microbiol Infect Dis. 1997 Jan;20(1):13-20. doi: 10.1016/s0147-9571(96)00030-6. Comp Immunol Microbiol Infect Dis. 1997. PMID: 9023036 Clinical Trial.
-
Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.Pediatrics. 1994 Apr;93(4):656-9. Pediatrics. 1994. PMID: 8134224 Clinical Trial.
-
The global impact of vaccines containing aluminium adjuvants.Vaccine. 2002 May 31;20 Suppl 3:S24-33. doi: 10.1016/s0264-410x(02)00168-8. Vaccine. 2002. PMID: 12184361 Review.
-
Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine.Vaccine. 1991 Oct;9(10):699-702. doi: 10.1016/0264-410x(91)90283-c. Vaccine. 1991. PMID: 1759487 Review.
Cited by
-
Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation.Clin Exp Immunol. 1985 Jul;61(1):143-51. Clin Exp Immunol. 1985. PMID: 3876178 Free PMC article.
-
Requirement of at least two distinct monoclonal antibodies for efficient neutralization of tetanus toxin in vivo.Naturwissenschaften. 1982 Dec;69(12):597-8. doi: 10.1007/BF00396359. Naturwissenschaften. 1982. PMID: 6186924 No abstract available.
-
Immunoglobulin E-suppressing and immunoglobulin G-enhancing tetanus toxoid prepared by conjugation with pullulan.Infect Immun. 1982 Jun;36(3):971-6. doi: 10.1128/iai.36.3.971-976.1982. Infect Immun. 1982. PMID: 7095857 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources